2016 CROSS-BORDER M&A CONFERENCE Investment, Digitization and Globalization in Times of Disruption

DATE Tuesday, September 20, 2016 TIME 9.00 am - 4.00 pm CEST VENUE Hotel Bayerischer Hof, Munich

Co-sponsored by Media Partners

In partnership with 2016 CROSS-BORDER M&A CONFERENCE Investment, Digitization and Globalization in Times of Disruption US/Europe and Asia/Europe Cross-Border M&A and Activist Shareholders

McDermott Will & Emery’s Munich M&A Conference In contrast with 2015, Q1of 2016 was considerably slow- (MuMAC) is celebrating its 6th year. We are looking forward er. M&A activity by deal volume globally was down by 24 to welcoming significant M&A market participants, strategic per cent this year, compared to Q1 of 2015. In the private and investors, and individuals from the advi- equity market, buy-outs were down by 15.3 per cent and sory world to take part in discussions on topics relating to exits by 29.7 per cent over the same period. Was this as a cross-border M&A. result of the markets preparing for the uncertainty surround- ing the United Kingdom’s Brexit Referendum, or a sign of We would very much like to thank in advance our key note something wider? speaker Callum Mitchell-Thomson, Head of Germany for J.P. Morgan Chase & Co., and the MuMAC 2016 is the best place to get answers from experts. many speakers participating in the panel discussions. Come and join us.

MuMAC 2016 will cover topics of major significance to the cross-border M&A markets, including regional investment trends in Europe, both from and into Asia and the United States. We will examine the effect of these trends on sectors Christian von Sydow Dr Nikolaus von Jacobs such as health; technology, media & telecoms; real estate and automotive. We will also, of course, be looking at the current and potential effect of Brexit on international M&A.

Since last year’s conference, the M&A market brightened dramatically. 2015 was a record year since 2008: the overall value of transactions in the European M&A market rose by 47 per cent to US$1,000 billion while the number of deals fell slightly to 6,361. Remarkably, the number of mega-deals increased significantly. The average deal size in Europe rose by 51.5 per cent to US$156 million. The top three most active industry sectors were consumer goods (21 per cent), health care (20 per cent) and TMT (14 per cent).

2015 also saw the highest cross-border deal volume since 2008. In all, 788 transactions (worth US$350 billion) were inbound from the United States, 585 (worth US$240 billion) outbound to the United States. A total of 311 transactions (worth US$86 billion) were inbound from Asia and 185 (worth US$16 billion) outbound to Asia.

2 MuMAC 2016 Invitation Conference Agenda

8.00 am – 9.00 am Registration and Continental Breakfast

9.00 am – 9.05 am Welcoming Remarks by Head of Transaction Group, McDermott Will & Emery Ira J. Coleman Grand Ballroom Global head of the Corporate & Transactional Practice, Miami

9.10 am – 9.50 am M&A and Private Equity Market 2016

Grand Ballroom Market snapshot Pricing and appetite Search for value Auction trends

Dr Michael Drill, CEO Germany and Managing Director, Lincoln International Dr Andreas Fendel, Quadriga Capital Philipp Haindl, Managing Director, Serafin Group Jan Mayerhöfer, Partner, Mayerhöfer & Co Corporate Finance Beratung Tristan Nagler, Managing Director, Aurelius Investments Steve Roberts, Private Equity Leader, PwC Germany

Moderator: Dr Nikolaus von Jacobs, Partner, McDermott Will & Emery

9.55 am – 10.15 am Cross Border M&A in the Shadow of Brexit

Grand Ballroom Callum Mitchell-Thomson, Head of Investment Banking Germany, J.P. Morgan

10.15 am – 10.45 am Coffee Break

MuMAC 2016 Invitation 3 Conference Agenda

10.45 am – 11.30 am Cross-Border M&A USA and Europe

Grand Ballroom Brexit and its impact on cross-border M&A The US capital markets and their role in technology M&A Key M&A sectors for US/European M&A in 2016 US and European companies: buyers or sellers?

Torsten Krumm, Managing Partner, HQ Equita Dr Jan Mathias Kuhr, Head of Corporate Law, KION GROUP Thomas Sauermilch, Partner, McDermott Will & Emery Patrick Schaich, Principal, Origination, Riverside Dr Burkhard Weber, Managing Director, Lincoln International

Moderator: Melville D. Mummert, Managing Director, Head of European Investment Banking, Raymond James

11.35 am – 12.15 pm Cross-Border M&A Asia and Europe

Grand Ballroom Chinese M&A activity in Europe: a long term trend or just hype? Chinese investors’ sector preferences and the question of the deal rationale behind their choices The real role of the Chinese Government in a typical deal How to run a global business with a Chinese shareholder

Junda (David) Dai, Partner, McDermott Will & Emery Dr Qing Ding, Chairman, Shenzhen Shentou Investment Co. Yongseok Jang, Executive Vice President and Head of Corporate Strategy Team, CJ Group Jacob Won, Managing Partner, Locus Capital Partners Dr Mei Wu, General Manager, Joyson Europe

Moderator: Wei Wang, Partner, PwC

12.15 pm – 1.15 pm Buffet Lunch Break

4 MuMAC 2016 Invitation Conference Agenda: Parallel Sessions

1.15 pm – 2.00 pm Parallel Sessions

Automotive, Digital Transformation and Private Equity

The convergence of the automotive, technology and mobility sectors A China – what will drive its growth in the next few years? Grand M&A versus cooperations/strategic partnerships Ballroom The future of private equity in the automotive industry

Florian Kähler, Partner, ECM Equity Capital Management Martin Schwarzer, Partner, PwC Mergers & Acquisitions Alexander Sixt, Member of the Executive Board for Organization and Strategy, Sixt Fabian Wasmus, Partner, EQT Partners Dr Thomas von Werner, Managing Director, Penta Investments

Moderator: Dr Joachim Koch, Partner, IMAP M&A Consultants

Life Sciences, Health and Private Equity: Licensing and Structured M&A Transactions

B The convergence of M&A and licencing Gallery Structured transactions in privately held companies v public M&A Litigation risk around due diligence obligations

Christoph Brandenberger, Managing Director, Healthios Capital Markets Dr Irina Staatz-Granzer, Founder and Managing Director, Staatz BD & Strategy Dr Sven Oleownik, Partner, Head, Gimv Germany Dr Erich Tauber, Chief Executive Officer, Co-Founder, Themis Bioscience Charlie Troup, Managing Partner, Dukestreet Kristian A. Werling, Partner, McDermott Will & Emery

Moderator: Emmanuelle Trombe, Partner, McDermott Will & Emery

MuMAC 2016 Invitation 5 Conference Agenda: Parallel Sessions

2.05 pm – 2.45 pm Parallel Sessions

TMT and Private Equity

Due diligence/valuation challenges in software businesses moving from license to SaaS A revenue models Grand Media or technology? Data-rich businesses with subscription revenues Ballroom Opportunities in the "internet of things" FinTec solutions to regulatory change Killer content: IP remains king but new distribution channels are changing the funding model

Christopher Brackmann, Director, Bridgepoint Olya Klüppel, Partner, ESO Capital Gunther Thies, Member of the Board, STP Informationstechnologie Mathias Wahrenberger, Managing Director, Burda Digital

Moderator: David Evans, Managing Director and European practice leader, Alvarez & Marsal

Cross-Border Real Estate

European real estate: safe haven or overpriced? B Teaming up: private equity meets German developers Gallery Outlook: is there any upside left?

Tobias Huzarski, Principal, KKR Kohlberg Kravis Roberts & Co. Partners Frank Müller, Executive Director Legal Affairs, Corpus Sireo Real Estate David Poremba, Director, Eastdil Secured Thomas Wiegand, Managing Director, Cerberus Deutschland

Moderator: Dr Jens Ortmanns, Partner, McDermott Will & Emery

6 MuMAC 2016 Invitation Conference Agenda

2.45 pm – 3.00 pm Coffee Break

3.00 pm – 3.15 pm Investment from the Gulf Region into Europe and the United States

Grand Ballroom Raed Fakhri Vice President, Investments, Bahrain Mumtalakat Holding Company (Mumtalakat)

3.20 pm – 4.00 pm Activist Shareholders: Experiences in the United States and Europe

Grand Ballroom Criteria for becoming a target Major challenges and obstacles for activists in Europe and the United States The performance of activist funds in Europe and the United States

Thomas Kolaya, Managing Director Germany and EGM, Alvarez & Marsal Roy Jacob Katzovic, Co-founder & Chairman of the Board, Saddle Point Group Till Hufnagel, Partner, Petrus Advisers Dr Olaf Marx, Managing Director, MCGM

Moderator: Bilal Sayyed, Partner, McDermott Will & Emery

4.00 pm – 4.30 pm Reception

MuMAC 2016 Invitation 7 Participants and Speakers

Christopher Brackmann and the related governmental approvals, statutory disclosure Director, Bridgepoint and post-closing integrations. David is admitted to the Chi- Christopher Brackmann is a member of the Business Ser- nese Bar and the New York State Bar. vices and Media & Technology Sector Teams at Bridgepoint, a pan-European private equity investor focused on acquiring Dr Qing Ding leading middle market businesses valued up to €1 billion. He Chairman, Shenzhen Shentou Investment Co. joined the firm in 2008 and spent his first seven years in the Qing Ding is the Chairman of Shenzhen Shentou Investment, office before becoming a member of the Frankfurt which he founded in 1998 with the backing of then the first team in 2016. Prior to joining Bridgepoint, he was an As- Chinese privatisation agency, Shenzhen Investment Holding sociate in the financial sponsors and leveraged finance team Co. Ltd. In 2001, Dr Ding took over the entire company. He at JPMorgan in London, where he was involved in numerous previously led FE Beratungs-und Beteiligungs GmbH, which European buy-outs. was founded in 1992.

Christoph Brandenberger Dr Michael Drill Managing Director, Healthios Capital Markets CEO Germany and Managing Director, Lincoln International Christoph Brandenberger is a Managing Director in the Chi- Michael Drill provides overall strategic and operational leader- cago office of Healthios Capital Markets, which offers stra- ship for the activities of Lincoln International, a global invest- tegic advisory and investment banking services to emerging ment bank, in German speaking countries. He has 20 years growth health care companies, where he focuses on a wide of experience in advising on corporate finance transactions, range of M&A, financing and strategic advisory mandates M&A, public takeovers, fairness opinions and corporate dives- in the medical devices sector. Prior to joining Healthios in titures. Prior to joining Lincoln, Dr Drill was Head of M&A at 2010, Mr Brandenberger worked in various operating roles the private bank Sal. Oppenheim in Frankfurt. Before that, he and ultimately as General Manager for a European multina- spent six years in the M&A group of Schroder Salamon Smith tional company. He started his career in corporate finance Barney Switzerland. and M&A at Montgomery Securities in Boston. David Evans Ira J. Coleman Managing Director and European Practice Leader, Alvarez & Global Head of the Corporate & Transactional Practice, Part- Marsal ner-in-Charge of the Miami office of McDermott Will & Emery David Evans recently joined Alvarez & Marsal, a leading glob- From the Miami office of law firm McDermott Will & Emery, al professional services firm, in London. With over 20 years Ira Coleman advises clients on matters related to health of experience, he specialises in providing financial advisory care mergers and acquisitions, health care private equity and and due diligence services to big ticket private equity spon- health systems. Mr Coleman has considerable experience sors and multinational corporate clients. He has worked on serving as counsel in connection with compliance matters over 100 cross-border transactions across a wide range of and the defence of anti-kickback and qui tam suits for health sectors, but has specific expertise in technology-, media- and care clients. content-rich businesses.

Junda (David) Dai Raed Fakhri Partner, MWE China Law Vice President, Investments, Bahrain Mumtalakat Holding Junda (David) Dai is based in the Shanghai office of the law Company (Mumtalakat) firm MWE China Law. With around 20 years of experience, Mr Raed Fakhri has been a Vice President, Investments at he has advised a variety of European and US clients, including Mumtalakat, the investment arm of the Kingdom of Bahrain, many Fortune 500 companies, in their direct investments in since March 2013. Mr Fakhri has enjoyed over 22 years of China by way of green-field investments, cross-border M&A, experience in various sectors, mainly in business develop- and private equity investments, and strategic ment and investments. In his current role, he is involved in alliances in a wide range of industries and areas, including setting and implementing the company’s investment strategy, manufacturing; infrastructure; technology, media & tele- and identifying, developing, and executing investment oppor- coms; chemicals and energy; health care; life sciences and tunities through joint ventures and acquisitions in the regional agriculture. David has also advised both sides of Chinese and global markets. In addition, he is charged with enhancing outbound investments in particular deal structuring, due dil- the value of existing portfolio assets by improving growth and igence, drafting and negotiation of transaction agreements, profitability, and developing strategic opportunities.

8 MuMAC 2016 Invitation Participants and Speakers

Dr Andreas Fendel Till Hufnagel Co-Founder and Managing Partner, Quadriga Capital Beteili- Partner and Head of Activism, Petrus Advisers gungsberatung Petrus Advisers is a Europe-focused long/short hedge fund Quadriga Capital is a leading midcap private equity adviso- based in London. In his role as Head of Activism, Till Huf- ry firm targeting the Germany, Austria, Switzerland region nagel is focused on entrepreneurial investing opportunities and neighbouring countries. Funds advised by the firm across Europe. He has 18 years of experience in the finan- have completed more than 150 transactions during the last cial industry, 14 of which were with Goldman Sachs Interna- 20 years. Its main activities relate to the industrial; services; tional, where he was a Managing Director in the Private Equity consumer/e-commerce; health care; and technology, media business. and telecoms sectors. The firm creates value by supporting management teams in transforming and growing businesses, Tobias Huzarski both organically and via buy-and-builds. Typical transaction Principal, KKR KKR Kohlberg Kravis Roberts & Co. Partners volumes range from €50 million to €300 million, and recent Tobias Huzarski joined KKR, an American multinational pri- examples include AHT Austria Haustechnik, Jack Wolfskin, vate equity firm, in 2012 and is a member of the European Ipsen, LR Health & Beauty, eterna, Lewa, Lapp Insulators, Real Estate Team, focusing on investments in Germany and punker, and DoreaFamilie. the United Kingdom. Prior to KKR, he worked for Orion Cap- ital Managers and Lehman Brothers in London. Dr Irina Staatz-Granzer Founder, Staatz Business Development & Strategy Dr Nikolaus von Jacobs Dr Irina Staatz has more than 20 years of experience in the Partner, McDermott Will & Emery pharmaceutical and biotechnology industry. Since 2006 she Nikolaus von Jacobs is based in the Munich office of law firm has specialised in advising and supporting leading venture McDermott Will & Emery, where he leads the Firm’s German capital firms and international biotech and pharmaceutical private equity team. He specialises in private equity, venture companies in devising the strategy for, and developing the capital and private and public M&A. In addition, he has vast operations of, their projects/product licencing, collaborations, experience in advising on distressed debt (non-performing divestments and M&A, on both the selling and buying sides. loan portfolios and single targets), distressed M&A and re- She has successfully negotiated a broad variety of agree- structuring. His clients are primarily private equity funds and ments with an aggregate deal value exceeding US$1.5 bil- German industrial market leaders. lion. Prior to launching Staatz, which provides strategic and operative business development solutions for customers in Yongseok Jang the health care sector, she held various senior management Executive Vice President and Head of Corporate Strategy positions in product development, was international marketing Team, CJ Group and business development at Hermal (Merck KGaA), Boots Yongseok Jang is a veteran business growth and develop- Healthcare International and Knoll (later Abbott), and served ment leader, with over 20 years of extensive global experi- as Chief Executive Officer of biotechnology companies Blink ence across the e-commerce, telecommunications and media Biomedical, Scil Technology and U3 Pharma, which was sold industries. Prior to joining CJ, a South Korean conglomerate to Daiichi Sankyo. Dr Staatz serves as Vice Chairman of the holding company, he served as head of strategy for LG Elec- Board of the public French biotech company Innate Pharma, tronics’ Mobile Division. and is Chairman of BliNK Biomedical, France. Roy Jacob Katzovicz Philipp Haindl Co-Founder & Chairman of the Board, Saddle Point Group Managing Director, Serafin Group Saddle Point is a public and private equity investment firm. Philipp Haindl is responsible for strategy and finance within Prior to joining Saddle Point, Roy Jacob Katzovicz served as the Serafin Group, a management consulting firm. He com- a Partner, Investment Team Member and Chief Legal Officer pleted his studies at a leading university in London with a of Pershing Square Capital Management, LP Before joining Master’s degree in economic history, and started his career Pershing Square, Mr Katzovicz was a corporate attorney at in asset management and audits, serving several mid-sized Wachtell, Lipton, Rosen & Katz, which he joined after serv- companies. Before founding Serafin, Mr Haindl was active ing as a judicial clerk to The Honorable William B. Chandler, in business analysis and acquisitions for five years and was Chancellor of the Delaware Court of Chancery. involved in numerous M&A transactions.

MuMAC 2016 Invitation 9 Participants and Speakers

Florian Kähler Olya Klüppel Partner, ECM Equity Capital Management Partner, ESO Capital Florian Kähler studied Business Administration and Econom- Olya Klueppel is a partner at ESO Capital. She manages ics in Germany and the United States. He worked for several ESO’s Zurich office. Prior to joining ESO in January 2010, Ms years at Deutsche Bank, first in the Leverage and Structured Klüppel was responsible for fund selection and portfolio man- Finance Department in Frankfurt, then in the Corporate Fi- agement of fixed income strategies, including direct lending nance Team. In 2009, Mr Kähler joined ECM, a manage- and special situations investments at Harcourt Investment ment-owned private equity firm, where he is responsible for Consulting AG, a diversified FoF now part of Vontobel. Fixed various transactions in different sectors, and his projects in- income accounted for $1+ billion of assets. From 2003 until clude Bergmann Automotive, Leitner and Kamps. 2006, Ms Klüppel sourced and executed public and private debt offerings in a variety of structures and currencies for Dr Joachim Koch sovereign and supranational clients at Citigroup. She has de- Partner, IMAP M&A Consultants veloped Citigroup’s European sub-sovereign franchise (local Joachim Koch focuses on sell- and buy-side transactions in authorities and government-guaranteed agencies). Prior to the automotive and industrials sector. He has more than 15 that Ms Klüppel spent several years in Tokyo advising corpo- years of experience, structuring M&A and financing transac- rate and sovereign issuers on raising capital in the Japanese tions for German and international companies, for both fam- capital markets. Ms Klüppel began her career in 1997 in ily-owned businesses and for private equity clients. Before the High Yield/Leveraged Finance Group at Salomon Smith joining IMAP, which advises on M&A transactions of all kind Barney in New York. with a focus on the middle market, Dr Koch worked for IKB Deutsche Industriebank, Société Générale and J.P. Morgan. Jan Mayerhöfer During his time at IKB, he had full responsibility for the auto- Partner, Mayerhöfer & Co Corporate Finance Beratung motive supplier industry. Mr Mayerhöfer has 20 years of experience in advising on national and international M&A transactions. In 2003 he Thomas Kolaja founded Mayerhöfer & Co, which provides financial advisory Managing Director, Germany and European Growth Markets, services. Prior to that, he spent eight years in the corporate Alvarez & Marsal Deutschland finance and M&A divisions of PricewaterhouseCoopers and Alvarez & Marsal Deutschland is a turnaround management the private bank Merck Finck & Co. and corporate restructuring firm, with offices in Munich, Prague and Warsaw. Thomas Kolaja heads the firm’s turn- Frank Müller around and performance improvement practice and has over Executive Director, Legal Affairs, CORPUS SIREO Real Estate 20 years of experience in restructuring, business strategy CORPUS SIREO is one of the leading German real estate and operational improvement advisory services. asset managers. Since 2014, it has been part of the Swiss Life Group, a leading European provider of comprehensive Torsten Krumm life and pensions and financial solutions. A qualified lawyer Managing Partner, HQ Equita and real estate economist, Frank Müller previously led the le- Torsten Krumm has been in the private equity industry for gal department of a large German real estate funds manager, 18 years. Prior to joining HQ Equita, which makes hands- and worked for several years in an international law firm. Mr on investments in small and mid-sized enterprises in Ger- Müller specialises in real estate and regulatory law. man-speaking regions, he was Co-Head of Odewald & Com- pagnie, a mid-cap private equity fund in Berlin. Before that, Dr Jan-Mathias Kuhr he was a Managing Partner at Apax Partners Germany for al- Head of Corporate Law, KION Group most 10 years. Mr Krumm previously worked for 10 years at Jan-Mathias Kuhr is responsible for corporate law matters Intel, where held the roles of Director at Intel Capital Europe, at KION Group AG. Mr Kuhr started his career at Baker & with responsibility for M&A and investments in Europe; Sales McKenzie, was Associate General Counsel at McKinsey and Marketing Manager, Europe; and Business Development & Co., and later General Counsel and Director Corporate and Marketing Manager, Australia and New Zealand. Before Development for Europe, the Middle East and Africa at Cel- joining Intel in Australia, he was the IT and Operation Manag- anese. He has broad experience in managing cross-border er at ITT in Australia and New Zealand, and started his career M&A transaction both from the perspective of an advisor as as a Corporate Key Account Manager at Novell Germany. well as from the in-house perspective as a deal manager.

10 MuMAC 2016 Invitation Participants and Speakers

Dr Olaf Marx Riverside) and medium-sized companies (Bionade, Jochen Managing Director, MCGM Schweizer, Frequentis, MEN and Runnerspoint). He has key Olaf Marx has more than 20 years of experience in top man- expertise in the consumer/retail and technology sectors. Pri- agement consulting. He possesses broad expertise including or to working for Deloitte, Mr Oleownik was a Partner in a strategic restructuring, corporate turnaround and optimisa- leading management consulting firm and in a medium-sized tion of business processes. Mr Marx has used these skills to investment company. In the course of his professional ca- benefit various industries but particularly the automotive, me- reer, he has guided more than 100 transactions, among them chanical and plant engineering, and financial sectors. Before several IPOs, and served as a member of the board for vari- founding MCGM, a consulting company with special knowl- ous companies, including Bionade, Bench and Regiolux. Mr edge in the areas of strategic new positioning, restructuring Oleownik represents Gimv on the board of Thinkstep. and optimisation of business processes, Mr Marx worked sev- eral years for Roland Berger Strategy Consultants. During Dr Jens Ortmanns his time at Roland Berger he successfully managed multiple Partner and Head of European Real Estate, McDermott Will complex projects for globally active corporations as well as & Emery leading medium-sized enterprises. Dr Jens Ortmanns is based in the Düsseldorf office of the law firm McDermott Will & Emery. He advises institutional inves- Melville D. Mummert tors, private equity funds, asset managers, insurer and pen- Managing Director and Head of European Investment Bank- sion funds, real estate consulting companies, family offices ing, Raymond James Financial Inc. and financial institutions from Austria, France, Germany, the United Kingdom and the United States. He has particularly Melville Mummert has acted as an advisor for cross-border extensive experience in acquisitions and sales (domestic and M&A, restructurings and privatisations in Europe since 1987. cross-border, single asset and portfolio transactions), asset Raymond James is a leading diversified financial services management-related advice, banking and finance, joint ven- company providing private client group, capital markets, as- ture investments and project developments. set management, banking and other services to individuals, corporations and municipalities. Before joining Raymond David Poremba James in 2016, Mr Mummert founded Mummert & Company Director at Eastdil Secured in 2001. Prior to that, he was a managing director at the Ma- tuschka Group in Munich and New York. Before joining the Eastdil Secured is the preeminent global real estate invest- Matuschka Group, Mr Mummert served as a managing direc- ment banking firm, providing best-in-class services for com- tor at ABN AMRO Corporate Finance in Germany, and held mercial real estate transactions, ranging from debt placement, management positions in technical sales at IBM Corporation. equity sales, recapitalisation, and corporate real estate activ- ities, across all asset classes and ranging from single assets Tristan Nagler to large platforms. Eastdil Secured’s clients benefit from a Managing Director, Aurelius Investments coordinated multi-level access to all capital sources, relation- ships with decision makers, and up-to-the-minute knowledge Tristan Nagler is managing director of Aurelius Investments of the market, investors and lenders. Mr Poremba focuses and leads the London Office. He spent 12 years in Mergers on pan-European and particularly German real estate trans- & Acquisitions and as a financier, before entering the world of actions. Prior to joining Eastdil Secured in 2012, he was a Private Equity. As Managing Director of Aurelius Investments, Director at pbb Deutsche Pfandbriefbank AG. Mr Nagler is responsible for Aurelius Equity Opportunities' in- vestment activities in the UK and Ireland. Steve Roberts Private Equity Leader, PwC Germany Dr Sven Oleownik Partner and Head, Gimv Germany Mr Roberts joined PwC UK in 1993, and qualified as an Associated Chartered Accountant in 1996. He joined the Sven Oleownik joined Gimv, a European investment company Transaction Services Team in January 1997 and has worked with experience in private equity and venture in 2015. Before exclusively within M&A since then. Having primarily worked that, Mr Oleownik headed Deloitte’s Corporate Finance Advi- on cross border transactions during his time in the United sory Team as a Managing Partner for 12 years. His clients at Kingdom, Mr Roberts transferred to the Frankfurt office in Deloitte included large corporates (such as BASF, Deutsche July 2001, where he focuses on serving the private equity Telekom, Lufthansa, Siemens and Volkswagen), private equi- market, and was promoted to partner in July 2005. He has ty firms (Apax, Carlyle, Emeram, EQT, Hannover Finanz and led the Private Equity Team since 2012. With wide experi-

MuMAC 2016 Invitation 11 Participants and Speakers

ence of various industries, and advising on both the buy-side pany strategy and M&A projects as well as the corporate effi- and sell-side, Mr Roberts has significant experience in large, ciency programs. In February of 2015 he has been appointed cross-border deals for private equity and corporate clients. to the Executive Board of the international mobility service provider SIXT SE. As an Executive Board Member for Organ- Tom Sauermilch ization and Strategy, Alexander Sixt is responsible for Group Partner, McDermott Will & Emery Strategy, M&A, Central Purchasing and Procurement, Process Mr Sauermilch is based in the New York office of law firm Management, global human resources and the management McDermott Will & Emery. He has particular experience in of all shared service and administration functions as well as cross-border M&A and joint venture transactions, and regu- the new mobility services such as DriveNow. Prior to joining larly advises clients on corporate governance and compliance SIXT, Mr Sixt was as a Senior Consultant at Roland Berger´s matters, including internal investigations in multiple countries. restructuring competence center. Prior to that Mr Sixt was a member of Deutsche Bank´s M&A Department in London. Bilal Sayyed Partner, McDermott Will & Emery Christian von Sydow Partner, McDermott Will & Emery Bilal Sayyed is based in the Washington DC office of the law firm McDermott Will & Emery, where he represents clients be- Christian von Sydow is based in the Munich office of law firm fore the Federal Trade Commission (FTC) and Department of McDermott Will & Emery. He specialises in corporate law, Justice in significant merger, civil and criminal antitrust mat- M&A, private equity, restructuring and corporate conflict reso- ters. In addition to his representation of clients in antitrust lution. Mr von Sydow has advised on numerous cross-border and competition matters, Mr Sayyed represents clients before M&A transactions across different industries. the FTC in consumer protection investigations. Dr Erich Tauber Patrick Schaich Chief Executive Officer and Co-Founder, Themis Bioscience Principal, The Riverside Company Themis Bioscience is an international biotech company spe- The Riverside Company is a global private equity firm fo- cialising in developing vaccines. Erich Tauber entered the cused on control and non-control investments in growing pharmaceutical and biotech industry in 2000, and held in businesses valued at up to US$400 million. Mr Schaich is roles with increasing responsibilities in AstraZeneca, Baxter, responsible for Riverside’s transaction origination activities Intercell and Nycomed. Dr Tauber is an expert in vaccine de- in German-speaking countries. Prior to joining Riverside in velopment and has substantial experience in the clinical and 2013, he served as Vice President, Investment Banking at regulatory field. Berenberg Bank and Associate, Investment Banking at Ke- pler Cheuvreux. He started his career as a Consultant, in the Gunther Thies Transaction Advisory Services Team at Ernst & Young. Founder and Member of the Board, STP Informationstechnologie Gunter Thies developed a software for liquidators – winsol- Martin Schwarzer venz – that was one of the first in the German market. To- Partner, PwC Mergers & Acquisitions day, winsolvenz is marketed by STP Informationstechnologie, Martin leads the German M&A team of PwC, based in the is used by over 1,000 liquidators and covers 70 per cent of Frankfurt office. He has over 20 years professional experi- the market. In addition to STP Informationstechnologie, Mr ence in M&A, private equity and going public and has worked Thies founded two other subsidiaries and has other equity for both German and international clients. Prior to joining investments, works as a “business angel”, and is a member of PwC, Mr Schwarzer was Vice President in the M&A depart- several advisory boards. ment of BNP Paribas and Investment Manager of Deutsche Beteiligungs AG, a leading German private equity company. Callum Mitchell-Thomson Mr Schwarzer specialises in the automotive sector and indus- Head of Investment Banking, Germany, J.P. Morgan trial products. Callum Mitchell-Thomson joined the European Energy Invest- ment Banking team of J.P. Morgan in 1997 and has advised Alexander Sixt on over 175 completed transactions, including some of the Member of the Executive Board for Organization and Strategy, Sixt most significant transactions in the energy sector in Europe Since June 2009 Mr Sixt has been Head of Corporate Devel- across oil and gas, power, and utilities. In 2006, he was ap- opment of SIXT SE. In that role he is responsible for all com- pointed Head of European Utilities and Co-Head of Europe-

12 MuMAC 2016 Invitation Participants and Speakers

an Energy Investment Banking. In 2012, he was appointed Fabian Wasmus Head of European Corporate Finance, with responsibility for Partner, EQT Partners setting up and managing a team of 260 banking profession- Fabian Wasmus joined EQT Partners, a Swedish private equi- als across nine European cities. In 2015, he was appointed ty group of 18 funds with €29 billion in raised capital, in 2006, Head of Investment Banking Germany and sits on the local and works on the EQT Mid Market Fund throughout Europe. management committee of J.P. Morgan’s German subsidiary. His areas of expertise include private equity and growth cap- ital, with a particular focus on technology and internet-related Emmanuelle Trombe investments. He started his career as the founder of an in- Partner, McDermott Will & Emery ternet start-up, and later worked for KPMG Advisory. Before Emmanuelle Trombe is based in the Paris office of law firm joining EQT he worked for a smaller, mid-cap private equity McDermott Will & Emery. She advises clients on matters in- fund in Frankfurt. Mr Wasmus is a Board Member of internet- volving corporate and general commercial law, with a focus stores, UDG, Roeser, Avenso and kfzteile24. on the pharmaceutical, medical device, biotech and health care industries. Dr Burkhard Weber Managing Director, Lincoln International Charlie Troup Burkhard Weber is a Managing Director of Lincoln Interna- Managing Partner, Duke Street Capital tional currently based in New York. In this role he advises cor- Charlie Troup joined Duke Street, a private equity firm focused porate clients, owner-managed businesses and private equity on and investments in houses primarily on cross-border transactions with a focus on middle-market companies in Western Europe, as a Partner in capital and durable consumer goods, industrial services, and 2006. He has led a number of deals including the acquisition paper & packaging markets. Burkhard has 19 years of M&A and realisation of SandpiperCI, Payzone and Laurel Funerals experience in advising on corporate finance transactions, both and the acquisition of Voyage Care, Baywater Healthcare in German speaking countries and North America. His clients and most recently MediGlobe, the international medical de- included large corporations, medium-sized privately-owned vices group based near Munich. He joined Duke Street from businesses and private equity groups. Burkhard joined Permira, where he had worked since 1995, becoming a Lincoln International in April 2010 in the Frankfurt office Partner in 2001. While at Permira, he worked on a range and relocated to New York in January 2014. Previously he of transactions including TGE, Memec, In-marsat and the was a Managing Director with Close Brothers for two years AA. Before Permira, Mr Troup spent two years with HSBC and prior served for 11 years in the financial advisory/M&A Private Equity (now Montagu Private Equity) on secondment practice of KPMG Corporate Finance in Berlin, Frankfurt from Deloitte, and Touche Corporate Finance, where he was a and Chicago. Prior to joining KPMG, Burkhard worked in senior manager specialising in raising private equity for MBI/ controlling and corporate development roles respectively at MBO transactions. Lufthansa and Franz Haniel & Cie, at the time one of Ger- many’s largest privately controlled, diversified services groups Dr Mathias Wahrenberger Managing Director, Burda Digital Wang Wei Burda Digital provides information technology services. Pri- Partner, Transactions Group, PwC or to being appointed Managing Director, Mathias Wahren- Wang Wei has more than 15 years of experience in advising berger led the Corporate Development Team of Burda Digital, international enterprises on their business expansion. Before which combines a variety of transactional and marketing-re- he joined PwC, Mr Wei was in charge of China transactions lated investments in internet companies. Dr Wahrenberger at other Big Four firms, particularly cross-border transactions worked for several years for the international strategy con- between Germany and China. His advice includes strategy sulting firm The Boston Consulting Group; as a Principal in and M&A transactions, due diligence and post merger inte- its Munich office, he advised companies from different indus- gration projects. tries on strategic issues and led various corporate transac- tions. He subsequently worked for Axel Springer, where he Kristian A. Werling was jointly responsible for the international expansion of Axel Partner, McDermott Will & Emery Springer Digital Classifieds, a strategic partnership with Gen- Kristian (Krist) Werling is based in the Chicago office of law eral Atlantic. firm McDermott Will & Emery, where he represents medical

MuMAC 2016 Invitation 13 Participants and Speakers

device and biopharmaceutical manufacturers, and health care small to mid-sized telecommunications companies for Dresd- service providers in a wide variety of transactional matters. ner Kleinwort Capital, the private equity arm of Dresdner He also represents private equity and venture capital inves- Bank group. From 2000 to 2001, he worked for Dresdner tors in investments in the life sciences and health care in- Kleinwort Wasserstein in Frankfurt, leading cash flow-related dustries. Mr Werling works with cross-disciplinary teams to financing projects in the telecom sector. Between 1999 and conduct legal due diligence and execute acquisitions, add-on 2000, Mr Wiegand was in the structured finance department acquisitions and divestitures, as well as provide ongoing legal of Dresdner Kleinwort Wasserstein in Sydney, Australia. services to portfolio companies. In the health care services arena, Mr Werling has particular experience with transactions Jacob Won and joint ventures involving ambulatory surgical centres, phy- Managing Partner, Locus Capital Partners sician and dental practices, and dialysis facilities. Locus Capital Partners is a Korea-based M&A advisory firm focusing on cross-border M&A in and out of Korea. Before Dr Thomas von Werner he joined Locus, Jacob Won was with KIMB Seoul, Goldman Country Managing Director, Germany, Penta Investments Sachs New York and Hong Kong, ING Baring Seoul and UBS Thomas von Werner joined Penta, a Central Europe invest- Hong Kong. ment group, in 2013, and is responsible for further develop- ment of Penta on the German market. He has more than Dr Mei Wu 15 years of experience in senior investment and business General Manager, Joyson Europe development roles. Before joining Penta, Dr von Werner was Mei Wu is a General Manager at Joysen Europe, which is a Senior Director at EQT Partners where he worked for seven subsidiary of Ningbo Joyson Electronic Corporation, a leading years. Prior to EQT Partners, he was Managing Director and global automotive supplier based in Ningbo, China. Before Partner at Odewald & Compagnie in Berlin. He started his joining Joysen Europe, Dr Wu worked as a lawyer at several career as a consultant for Bain & Company in Munich. law firms in Germany.

Thomas Wiegand Managing Director, Cerberus Deutschland Beteiligungsber- atung Thomas Wiegand joined Cerberus Deutschland Beteiligungs- beratung, which offers advisory services to Cerberus Capi- tal Management LLC for business activities in Germany, in 2005. Prior to joining Cerberus, Mr Wiegand worked in the institutional restructuring unit of Dresdner Bank from 2003 to 2005, where he was a Director responsible for the sale of non-performing loan portfolios to opportunity investors and the sale of non-core holdings of Dresdner Bank. From 2001 to 2003, he focused on restructuring investments in German

If you have any questions regarding this event, please contact us. Content: Christian von Sydow Tel: +49 89 12712 141 E-mail: [email protected] Event management: Anna-Maria Bokelmann, Tel: +49 89 12712 141 E-mail: [email protected] MuMAC is organised for McDermott Will & Emery by MWE Training UG (haftungsbeschränkt), Nymphenburger Str. 3, 80335 Munich

14 MuMAC 2016 Invitation Registration

When: Tuesday, September 20, 2016, 9.00 am – 4.00 pm CEST Where: Hotel Bayerischer Hof, Promenadeplatz 2-6, 80333 Munich, Germany

CONFERENCE FEE: €250 plus19 per cent VAT

Terms and Conditions: The fee for this event, which is payable plus tax, is due upon receipt of the invoice. The invoice will be e-mailed to you under separate cover and payment should be made to MWE Training UG (haftungsbeschränkt). Registration is complete only after receipt of the fee. Refunds are available up to 14 days prior to the event and only if cancellation is notified in writing to mucmwetraining@ mwe.com, otherwise the entire fee is due. We are happy to accept a replacement attendee at no additional charge. We reserve the right to restrict participation.

We look forward to receiving your registration:

Please register via http://kurzelinks.de/MuMAC2016 or e-mail name, title, company, e-mail address and telephone number to Anna-Maria Bokelmann at [email protected] or complete the following and return by post to MWE Training UG (haftungsbeschränkt), Anna-Maria Bokelmann, c/o McDermott Will & Emery, Nymphenburger Str. 3, 80335 Munich, Germany or fax to Anna-Maria Bokelmann on +49 89 12712 111

 Yes, I will join the conference as participant

 No, I am not able to attend the conference but would like to receive further information. Please send to my email address.

Name

Title

Company

Address

City Country

Telephone

Fax

E-Mail MuMAC 2016 Invitation 15 We sincerely thank our event partners:

Co-sponsored by

In partnership with

Media Partner

MWE Training UG (haftungsbeschränkt)‘s MuMAC Munich M&A Conference 2016 will be of value to company presidents, CEOs, general counsel or other executives with an interest in cross-border M&A. Please be advised MWE Training UG (haftungsbeschränkt) has the right to restrict attendance and may limit participation in this event.